Reference
1. J. FW, J. LV, Hopkins C. ea. European Position Paper on
Rhinosinusitis and Nasal Polyps 2020. 2020.
2. Davies G, Lam M, Harris SE, et al. Study of 300,486
individuals identifies 148 independent genetic loci influencing general
cognitive function. Nat Commun. May 29 2018;9(1):2098.
3. Fokkens WJ, Lund VJ, Mullol J, et al. European Position
Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. Mar
2012;23:3 p preceding table of contents, 1-298.
4. J M Greve, G Davis, A M Meyer, et al. The major human
rhinovirus receptor is ICAM-1. Cell 1989;56:839-947.
5. Sugrue RJ. Interactions between respiratory syncytial virus
and the host cell: opportunities for antivirus strategies? Expert
Rev Mol Med. Sep 5 2006;8(21):1-17.
6. van Cauwenberge P, Ingels K. Effects of viral and bacterial
infection on nasal and sinus mucosa. Acta Otolaryngol. Mar
1996;116(2):316-321.
7. A Wanner, M Salathé, O’Riordan TG. Mucociliary clearance in
the airways. American journal of respiratory and critical care
medicine 1996;154:1868-1902.
8. Banks C, Freeman L, Cho DY, Woodworth BA. Acquired cystic
fibrosis transmembrane conductance regulator dysfunction. World J
Otorhinolaryngol Head Neck Surg. Sep 2018;4(3):193-199.
9. Cabrini G, Rimessi A, Borgatti M, et al. Role of Cystic
Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis. Front
Immunol. 2020;11:1438.
10. J. FW, J. LV, Mullol J. ea. European position paper on
rhinosinusitis and nasal polyps 2007. 2007.
11. Basharat U, Aiche MM, Kim MM, Sohal M, Chang EH. Are
rhinoviruses implicated in the pathogenesis of sinusitis and chronic
rhinosinusitis exacerbations? A comprehensive review. Int Forum
Allergy Rhinol. Oct 2019;9(10):1159-1188.
12. Passariello C, Schippa S, Conti C, et al. Rhinoviruses
promote internalisation of Staphylococcus aureus into non-fully
permissive cultured pneumocytes. Microbes Infect. Mar
2006;8(3):758-766.
13. Groman JD, Meyer ME, Wilmott RW, Zeitlin PL, Cutting GR.
Variant cystic fibrosis phenotypes in the absence of CFTR mutations.N Engl J Med. Aug 8 2002;347(6):401-407.
14. Yan Y, Tan KS, Li C, et al. Human nasal epithelial cells
derived from multiple subjects exhibit differential responses to H3N2
influenza virus infection in vitro. J Allergy Clin Immunol. Jul
2016;138(1):276-281 e215.
15. Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL.
Neutrophil-derived cytokines: potential therapeutic targets in
inflammation. Curr Drug Targets Inflamm Allergy. Jun
2005;4(3):273-279.
16. Kolaczkowska E, Kubes P. Neutrophil recruitment and
function in health and inflammation. Nat Rev Immunol. Mar
2013;13(3):159-175.
17. Mott LS, Park J, Murray CP, et al. Progression of early
structural lung disease in young children with cystic fibrosis assessed
using CT. Thorax. Jun 2012;67(6):509-516.
18. Guo T, Ma H, Zhou Y. Bioinformatics analysis of microarray
data to identify the candidate biomarkers of lung adenocarcinoma.PeerJ. 2019;7:e7313.
19. Nguyen TN, Do BH, Kitamura T, et al. Expression of Cl(-)
channels/transporters in nasal polyps. Eur Arch Otorhinolaryngol.Aug 2020;277(8):2263-2270.
20. Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis
with Nasal Polyps. J Allergy Clin Immunol Pract. Jul-Aug
2016;4(4):565-572.
21. Woodworth BA. Resveratrol ameliorates abnormalities of
fluid and electrolyte secretion in a hypoxia-Induced model of acquired
CFTR deficiency. Laryngoscope. Oct 2015;125 Suppl 7:S1-S13.
22. Guimbellot JS, Fortenberry JA, Siegal GP, et al. Role of
oxygen availability in CFTR expression and function. Am J Respir
Cell Mol Biol. Nov 2008;39(5):514-521.
23. Huabin L, Yuting L, J W. Endotypes and precision medicine
in chronic sinusitis reatment. J Otolaryngol Ophthalmol Shandong
Univ. 2019;33:9-13.
24. Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine
profiles in patients with chronic rhinosinusitis: A multicenter study in
Europe, Asia, and Oceania. J Allergy Clin Immunol. Nov
2016;138(5):1344-1353.
25. Zheng H, Tang L, Song B, et al. Inflammatory patterns of
antrochoanal polyps in the pediatric age group. Allergy Asthma
Clin Immunol. 2019;15:39.